Instrumentarium Imaging (Hall B, #8303) has kept a lower profile than some of its mammography competitors regarding the development of digital mammography technology, but that will begin to change at this year's meeting. The Milwaukee company will
Instrumentarium Imaging (Hall B, #8303) has kept a lower profile than some of its mammography competitors regarding the development of digital mammography technology, but that will begin to change at this year's meeting. The Milwaukee company will display Delta16 TACT (tuned-aperture computed tomography), a work-in-progress digital system that may give the company a unique selling point.
Delta16 TACT acquires 2-D digital slices of mammography data acquired from different angles and positions, and reconstructs the data into 3-D images. Tuned aperture refers to the opening through which the breast is viewed, and tuning the aperture's size and shape determines the 3-D picture's degree of completeness.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.